Author
Listed:
- Emily M. Beydler
(Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
Penn Center for Women’s Behavioral Wellness, University of Pennsylvania, Philadelphia, PA 19104, USA)
- Amanda Koire
(AMC Department of Psychiatry, Mass General Brigham, Boston, MA 02115, USA
Mary Horrigan Connors Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital, Boston, MA 02115, USA
Harvard Medical School, Boston, MA 02115, USA)
- Elizabeth Steuber
(Harvard Medical School, Boston, MA 02115, USA
Department of Psychiatry, Boston Children’s Hospital, Boston, MA 02115, USA)
- Joseph J. Taylor
(AMC Department of Psychiatry, Mass General Brigham, Boston, MA 02115, USA
Harvard Medical School, Boston, MA 02115, USA
Center for Brain Circuit Therapeutics, Mass General Brigham, Boston, MA 02115, USA)
- Reid J. Mergler
(Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
Penn Center for Women’s Behavioral Wellness, University of Pennsylvania, Philadelphia, PA 19104, USA)
Abstract
Perinatal depression affects approximately 1 in 5 women and is the leading cause of maternal mortality in the United States. In addition to evidence-based treatment with antidepressant medications, there has been a push to identify rapid-acting options for pregnant and postpartum individuals. This paper reviews the evidence behind new pharmacological agents (neurosteroids and ketamine) and non-pharmacological approaches (transcranial magnetic stimulation). The paper also highlights the risks and benefits of electroconvulsive therapy and selective serotonin reuptake inhibitors. Based on recent studies and research, the paper provides considerations when prescribing these modalities including: timing of symptom onset, severity of presentation, breastfeeding priorities, prior treatment response and treatment availability and cost.
Suggested Citation
Emily M. Beydler & Amanda Koire & Elizabeth Steuber & Joseph J. Taylor & Reid J. Mergler, 2025.
"Rapid-Acting Treatments for Perinatal Depression: Clinical Landscapes and Future Horizons,"
IJERPH, MDPI, vol. 22(4), pages 1-11, April.
Handle:
RePEc:gam:jijerp:v:22:y:2025:i:4:p:546-:d:1626652
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:22:y:2025:i:4:p:546-:d:1626652. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.